Literature DB >> 23508685

Repressive epigenetic changes at the mGlu2 promoter in frontal cortex of 5-HT2A knockout mice.

Mitsumasa Kurita1, José L Moreno, Terrell Holloway, Alexey Kozlenkov, Giuseppe Mocci, Aintzane García-Bea, James B Hanks, Rachael Neve, Eric J Nestler, Scott J Russo, Javier González-Maeso.   

Abstract

Serotonin 5-HT(2A) and metabotropic glutamate 2 (mGlu2) are G protein-coupled receptors suspected in the pathophysiology of psychiatric disorders, such as schizophrenia, depression, and suicide. Previous findings demonstrate that mGlu2 mRNA expression is down-regulated in brain cortical regions of 5-HT2A knockout (KO) mice. However, the molecular mechanism responsible for this alteration remains unknown. We show here repressive epigenetic changes at the promoter region of the mGlu2 gene in frontal cortex of 5-HT(2A)-KO mice. Disruption of 5-HT(2A) receptor-dependent signaling in mice was associated with decreased acetylation of histone H3 (H3ac) and H4 (H4ac) and increased tri-methylation of histone H3 at lysine 27 (H3K27me3) at the mGlu2 promoter, epigenetic changes that correlate with transcriptional repression. Neither methylation of histone H3 at lysine 4 (H3K4me1/2/3) nor tri-methylation of histone H3 at lysine 9 (H3K9me3) was affected. We found that Egr1, a transcription factor in which promoter activity was positively regulated by the 5-HT(2A) receptor agonist 4-bromo-3,6-dimethoxybenzocyclobuten-1-yl)methylamine hydrobromide, binds less to the mGlu2 promoter in frontal cortex of 5-HT(2A)-KO, compared with wild-type mice. Furthermore, expression of mGlu2 was increased by viral-mediated gene transfer of FLAG-tagged Egr1 in mouse frontal cortex. Together, these observations suggest that 5-HT(2A) receptor-dependent signaling epigenetically affects mGlu2 transcription in mouse frontal cortex.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23508685      PMCID: PMC3657099          DOI: 10.1124/mol.112.084582

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  51 in total

Review 1.  Neurotransmitter interactions in schizophrenia--therapeutic implications.

Authors:  A Carlsson; N Waters; M L Carlsson
Journal:  Biol Psychiatry       Date:  1999-11-15       Impact factor: 13.382

Review 2.  Covalent modifications of histones during development and disease pathogenesis.

Authors:  Sukesh R Bhaumik; Edwin Smith; Ali Shilatifard
Journal:  Nat Struct Mol Biol       Date:  2007-11-05       Impact factor: 15.369

3.  Decoding the signaling of a GPCR heteromeric complex reveals a unifying mechanism of action of antipsychotic drugs.

Authors:  Miguel Fribourg; José L Moreno; Terrell Holloway; Davide Provasi; Lia Baki; Rahul Mahajan; Gyu Park; Scott K Adney; Candice Hatcher; José M Eltit; Jeffrey D Ruta; Laura Albizu; Zheng Li; Adrienne Umali; Jihyun Shim; Alexandre Fabiato; Alexander D MacKerell; Vladimir Brezina; Stuart C Sealfon; Marta Filizola; Javier González-Maeso; Diomedes E Logothetis
Journal:  Cell       Date:  2011-11-23       Impact factor: 41.582

Review 4.  Glutamatergic transmission in schizophrenia: from basic research to clinical practice.

Authors:  Joshua Kantrowitz; Daniel C Javitt
Journal:  Curr Opin Psychiatry       Date:  2012-03       Impact factor: 4.741

5.  Persistent effects of chronic clozapine on the cellular and behavioral responses to LSD in mice.

Authors:  José L Moreno; Terrell Holloway; Adrienne Umali; Vinayak Rayannavar; Stuart C Sealfon; Javier González-Maeso
Journal:  Psychopharmacology (Berl)       Date:  2012-07-28       Impact factor: 4.530

6.  Chronic treatment with LY341495 decreases 5-HT(2A) receptor binding and hallucinogenic effects of LSD in mice.

Authors:  José L Moreno; Terrell Holloway; Vinayak Rayannavar; Stuart C Sealfon; Javier González-Maeso
Journal:  Neurosci Lett       Date:  2013-01-16       Impact factor: 3.046

7.  Identification of three residues essential for 5-hydroxytryptamine 2A-metabotropic glutamate 2 (5-HT2A·mGlu2) receptor heteromerization and its psychoactive behavioral function.

Authors:  José L Moreno; Carolina Muguruza; Adrienne Umali; Steven Mortillo; Terrell Holloway; Fuencisla Pilar-Cuéllar; Giuseppe Mocci; Jeremy Seto; Luis F Callado; Rachael L Neve; Graeme Milligan; Stuart C Sealfon; Juan F López-Giménez; J Javier Meana; Deanna L Benson; Javier González-Maeso
Journal:  J Biol Chem       Date:  2012-11-05       Impact factor: 5.157

Review 8.  Epigenetic mechanisms in neurological disease.

Authors:  Mira Jakovcevski; Schahram Akbarian
Journal:  Nat Med       Date:  2012-08       Impact factor: 53.440

9.  Dysregulated 5-HT(2A) receptor binding in postmortem frontal cortex of schizophrenic subjects.

Authors:  Carolina Muguruza; José L Moreno; Adrienne Umali; Luis F Callado; J Javier Meana; Javier González-Maeso
Journal:  Eur Neuropsychopharmacol       Date:  2012-11-21       Impact factor: 4.600

10.  HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity.

Authors:  Mitsumasa Kurita; Terrell Holloway; Aintzane García-Bea; Alexey Kozlenkov; Allyson K Friedman; José L Moreno; Mitra Heshmati; Sam A Golden; Pamela J Kennedy; Nagahide Takahashi; David M Dietz; Giuseppe Mocci; Ane M Gabilondo; James Hanks; Adrienne Umali; Luis F Callado; Amelia L Gallitano; Rachael L Neve; Li Shen; Joseph D Buxbaum; Ming-Hu Han; Eric J Nestler; J Javier Meana; Scott J Russo; Javier González-Maeso
Journal:  Nat Neurosci       Date:  2012-08-05       Impact factor: 24.884

View more
  12 in total

1.  Differences in 5-HT2A and mGlu2 Receptor Expression Levels and Repressive Epigenetic Modifications at the 5-HT2A Promoter Region in the Roman Low- (RLA-I) and High- (RHA-I) Avoidance Rat Strains.

Authors:  Luna Fomsgaard; Jose L Moreno; Mario de la Fuente Revenga; Tomasz Brudek; Dea Adamsen; Cristobal Rio-Alamos; Justin Saunders; Anders Bue Klein; Ignasi Oliveras; Toni Cañete; Gloria Blazquez; Adolf Tobeña; Albert Fernandez-Teruel; Javier Gonzalez-Maeso; Susana Aznar
Journal:  Mol Neurobiol       Date:  2017-03-06       Impact factor: 5.590

2.  HDAC2-dependent Antipsychotic-like Effects of Chronic Treatment with the HDAC Inhibitor SAHA in Mice.

Authors:  Mario de la Fuente Revenga; Daisuke Ibi; Justin M Saunders; Travis Cuddy; Maryum K Ijaz; Rudy Toneatti; Mitsumasa Kurita; Terrell Holloway; Li Shen; Jeremy Seto; Mikhail G Dozmorov; Javier González-Maeso
Journal:  Neuroscience       Date:  2018-07-17       Impact factor: 3.590

3.  Antipsychotic-induced Hdac2 transcription via NF-κB leads to synaptic and cognitive side effects.

Authors:  Daisuke Ibi; Mario de la Fuente Revenga; Nebojsa Kezunovic; Carolina Muguruza; Justin M Saunders; Supriya A Gaitonde; José L Moreno; Maryum K Ijaz; Vishaka Santosh; Alexey Kozlenkov; Terrell Holloway; Jeremy Seto; Aintzane García-Bea; Mitsumasa Kurita; Grace E Mosley; Yan Jiang; Daniel J Christoffel; Luis F Callado; Scott J Russo; Stella Dracheva; Juan F López-Giménez; Yongchao Ge; Carlos R Escalante; J Javier Meana; Schahram Akbarian; George W Huntley; Javier González-Maeso
Journal:  Nat Neurosci       Date:  2017-08-07       Impact factor: 24.884

4.  Chronic treatment with a metabotropic mGlu2/3 receptor agonist diminishes behavioral response to a phenethylamine hallucinogen.

Authors:  Adam L Halberstadt; Jochem V F van der Zee; Muhammad Chatha; Mark A Geyer; Susan B Powell
Journal:  Psychopharmacology (Berl)       Date:  2018-11-17       Impact factor: 4.530

Review 5.  Epigenetic Mechanisms of Serotonin Signaling.

Authors:  Terrell Holloway; Javier González-Maeso
Journal:  ACS Chem Neurosci       Date:  2015-03-10       Impact factor: 4.418

Review 6.  Reprogramming of mPFC transcriptome and function in alcohol dependence.

Authors:  M Heilig; E Barbier; A L Johnstone; J Tapocik; M W Meinhardt; S Pfarr; C Wahlestedt; W H Sommer
Journal:  Genes Brain Behav       Date:  2016-11-24       Impact factor: 3.449

7.  HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice.

Authors:  Terrell Holloway; Jose L Moreno; Javier González-Maeso
Journal:  J Vis Exp       Date:  2016-07-09       Impact factor: 1.355

8.  Acute ethanol alters multiple histone modifications at model gene promoters in the cerebral cortex.

Authors:  Andrey Finegersh; Gregg E Homanics
Journal:  Alcohol Clin Exp Res       Date:  2014-06-18       Impact factor: 3.455

Review 9.  NMDA receptor hypofunction for schizophrenia revisited: Perspectives from epigenetic mechanisms.

Authors:  Melissa A Snyder; Wen-Jun Gao
Journal:  Schizophr Res       Date:  2019-04-09       Impact factor: 4.939

10.  Functional associations among G protein-coupled neurotransmitter receptors in the human brain.

Authors:  Skirmantas Janušonis
Journal:  BMC Neurosci       Date:  2014-01-17       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.